Severe Hemorrhagic Transformation after Thrombolysis for Acute Ischemic Stroke Prevents Early Neurological Improvement

被引:15
作者
Gill, Dipender [1 ]
Baheerathan, Aravindhan [2 ]
Aravind, Adarsh [3 ]
Veltkamp, Roland [4 ]
Kar, Arindam [3 ]
机构
[1] Imperial Coll London, Hammersmith Hosp, Postgrad Ctr, Imperial Coll Healthcare NHS Trust, London, England
[2] Univ Coll London Hosp, Univ Coll London Hosp NHS Fdn Trust, London, England
[3] Charing Cross Hosp, Imperial Coll Healthcare NHS Trust, London, England
[4] Imperial Coll London, Dept Stroke Med, Div Brain Sci, London, England
关键词
Intracerebral hemorrhage; hemorrhagic transformation; ischemic stroke; rtPA; thrombolysisstroke; subtype; INTRAVENOUS THROMBOLYSIS; ALTEPLASE;
D O I
10.1016/j.jstrokecerebrovasdis.2016.04.020
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Intravenous thrombolysis can improve neurological outcomes after acute ischemic stroke (AIS), but hemorrhagic transformation (HT) of the infarct remains a risk. Current definitions for symptomatic intracerebral hemorrhage (ICH) all entail that there be some degree of associated neurological deterioration. However, early deleterious effects of secondary ICH might also be manifested as reduced neurological improvement. This study aims to investigate whether there are any independent associations between different radiological subtypes of HT and the degree of neurological improvement 24 hours after thrombolysis. Methods: This study is a retrospective analysis of a single-center database of consecutive thrombolysis cases for AIS. Multivariate regression analysis was undertaken to explore the relationship between different subtypes of HT with changes in National Institutes of Health Stroke Scale (NIHSS) score 24 hours after thrombolysis, after adjusting for potential confounders. Results: As compared to cases with no HT, occurrence of the parenchymal hematoma 2 (PH2) subtype of secondary ICH was independently associated with reduced improvement or worsening in the NIHSS score, with an average effect size of 7 points (95% confidence interval -10 to -4, P < .001). In the absence of PH2, thrombolysis for AIS was generally associated with an improvement in the neurological status at 24 hours. Conclusions: The PH2 subtype of HT is associated with reduced neurological improvement or deterioration 24 hours after thrombolysis for AIS.
引用
收藏
页码:2232 / 2236
页数:5
相关论文
共 13 条
[1]   Early and Late Mortality of Spontaneous Hemorrhagic Transformation of Ischemic Stroke [J].
D'Amelio, Marco ;
Terruso, Valeria ;
Famoso, Giorgia ;
Di Benedetto, Norma ;
Realmuto, Sabrina ;
Valentino, Francesca ;
Ragonese, Paolo ;
Savettieri, Giovanni ;
Aridon, Paolo .
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2014, 23 (04) :649-654
[2]   Asymptomatic hemorrhage after thrombolysis may not be benign - Prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study registry [J].
Dzialowski, Imanuel ;
Pexman, J. H. Warwick ;
Barber, Philip A. ;
Demchuk, Andrew M. ;
Buchan, Alastair M. ;
Hill, Michael D. .
STROKE, 2007, 38 (01) :75-79
[3]   Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials [J].
Emberson, Jonathan ;
Lees, Kennedy R. ;
Lyden, Patrick ;
Blackwell, Lisa ;
Albers, Gregory ;
Bluhmki, Erich ;
Brott, Thomas ;
Cohen, Geoff ;
Davis, Stephen ;
Donnan, Geoffrey ;
Grotta, James ;
Howard, George ;
Kaste, Markku ;
Koga, Masatoshi ;
von Kummer, Ruediger ;
Lansberg, Maarten ;
Lindley, Richard I. ;
Murray, Gordon ;
Olivot, Jean Marc ;
Parsons, Mark ;
Tilley, Barbara ;
Toni, Danilo ;
Toyoda, Kazunori ;
Wahlgren, Nils ;
Wardlaw, Joanna ;
Whiteley, William ;
del Zoppo, Gregory J. ;
Baigent, Colin ;
Sandercock, Peter ;
Hacke, Werner .
LANCET, 2014, 384 (9958) :1929-1935
[4]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[5]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[6]   Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke [J].
Hacke, Werner ;
Kaste, Markku ;
Bluhmki, Erich ;
Brozman, Miroslav ;
Davalos, Antoni ;
Guidetti, Donata ;
Larrue, Vincent ;
Lees, Kennedy R. ;
Medeghri, Zakaria ;
Machnig, Thomas ;
Schneider, Dietmar ;
von Kummer, Ruediger ;
Wahlgren, Nils ;
Toni, Danilo .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) :1317-1329
[7]   Predictors and Early Outcome of Hemorrhagic Transformation after Acute Ischemic Stroke [J].
Kablau, Micha ;
Kreisel, Stefan H. ;
Sauer, Tamara ;
Binder, Johannes ;
Szabo, Kristina ;
Hennerici, Michael G. ;
Kern, Rolf .
CEREBROVASCULAR DISEASES, 2011, 32 (04) :334-341
[8]   The stroke-thrombolytic predictive instrument - A predictive instrument for intravenous thrombolysis in acute ischemic stroke [J].
Kent, David M. ;
Selker, Harry P. ;
Ruthazer, Robin ;
Bluhmki, Erich ;
Hacke, Werner .
STROKE, 2006, 37 (12) :2957-2962
[9]  
Little R. J., 2019, Statistical analysis with missing data, V793
[10]   TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].
MARLER, JR ;
BROTT, T ;
BRODERICK, J ;
KOTHARI, R ;
ODONOGHUE, M ;
BARSAN, W ;
TOMSICK, T ;
SPILKER, J ;
MILLER, R ;
SAUERBECK, L ;
JARRELL, J ;
KELLY, J ;
PERKINS, T ;
MCDONALD, T ;
RORICK, M ;
HICKEY, C ;
ARMITAGE, J ;
PERRY, C ;
THALINGER, K ;
RHUDE, R ;
SCHILL, J ;
BECKER, PS ;
HEATH, RS ;
ADAMS, D ;
REED, R ;
KLEI, M ;
HUGHES, S ;
ANTHONY, J ;
BAUDENDISTEL, D ;
ZADICOFF, C ;
RYMER, M ;
BETTINGER, I ;
LAUBINGER, P ;
SCHMERLER, M ;
MEIROSE, G ;
LYDEN, P ;
RAPP, K ;
BABCOCK, T ;
DAUM, P ;
PERSONA, D ;
BRODY, M ;
JACKSON, C ;
LEWIS, S ;
LISS, J ;
MAHDAVI, Z ;
ROTHROCK, J ;
TOM, T ;
ZWEIFLER, R ;
DUNFORD, J ;
ZIVIN, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587